Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001396677-11-000036
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-09-30 17:00:03
Reporting Period:
2011-09-28
Filing Date:
2011-09-30
Filing Date Changed:
2011-09-30
Accepted Time:
2011-09-30 18:00:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1050007 Nutraceutical International Corp NUTR Medicinal Chemicals & Botanical Products (2833) 870515089
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1079725 Ii W Frank Gay Nutracetical International Corp
1400 Kearns Blvd 2Nd Fl.
Park City UT 84060
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-09-28 1,300 $3.50 729,199 No 4 M Direct
Common Stock Disposition 2011-09-28 1,300 $13.12 727,899 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2011-09-28 1,300 $0.00 1,300 $3.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
55,800 2011-12-13 No 4 M Direct
Footnotes
  1. Exercise of options expiring on December 13, 2011.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2011.
  3. The price shown in Column 4 is a weighted average. The price range for the sales is $13.00 to $13.17. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. The option vested in six equal installments beginning on June 13, 2002.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!